Skip to content

Effect of Unani drug on Dyslipidemia

Efficacy of Arq-e-Biranjasif in Dyslipidemia â?? A Randomized Open labelled Standard Controlled Study

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2020/09/027924
Enrollment
100
Registered
2020-09-21
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: I998- Other disorder of circulatory system

Interventions

Intervention1: Arq Biranjasif: Arq-e-Biranjasif 125ml once a day before meal orally for 8 weeks Control Intervention1: Tab.Atorvastatin: Tab.Atorvastatin 10mg once a day orally for 8 weeks

Sponsors

National Institute of Unani Medicine
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Known cases of Dyslipidemia with disease history of Total Cholesterol > 200- 239mg / dl27 Triglycerides LDL >189 mg / dl27 HDL VLDL >0.930â??1.006 g/ L5 Ratio HDL to LDL Patients of both sex Age: between 20-50 yrs BMI Known cases of DM type -2 with Dyslipidemia Fasting blood sugar (FBS) > 126 mg/dl - Post Prandial blood sugar (PPBS) > 140 mg/dl - Normotensives ( Patients who follow the protocol

Exclusion criteria

Exclusion criteria: Known cases of Dyslipidemia, with disease history of > 3yrs Total Cholesterol > 240 mg / dl Triglycerides > 499 mg / dl (High)27 LDL HDL > 70 mg / dl VLDL Ratio LDL to HDL >6.3 in men and >5 in woman Known cases of Type 2 Diabetes Mellitus with complications. Fasting Blood Sugar >150 mg/dl32 Post Prandial blood sugar (PPBS) > 250mg/dl Known cases of Hypertension 33Diabetes Mellitus type I, Hypothyroidism Known cases on use of corticosteroids, and contraceptives. History of cardiovascular, Renal, Liver diseases, AIDS and T.B. History of alcoholism BMI >= 40 Pregnant & lactating mothers Age 50 years of age

Design outcomes

Primary

MeasureTime frame
Changes in Lipid profileTimepoint: 8 weeks

Secondary

MeasureTime frame
NilTimepoint: Nil

Countries

India

Contacts

Public ContactFAROOQUI SHAZIA PARVEEN

National Institute of Unani Medicine

drmaquamri@gmail.com9341072974

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026